iShares US Pharmaceuticals ETF
IHE
IHE
87 hedge funds and large institutions have $111M invested in iShares US Pharmaceuticals ETF in 2019 Q2 according to their latest regulatory filings, with 11 funds opening new positions, 15 increasing their positions, 37 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
87
Holders Change
-4
Holders Change %
-4.4%
% of All Funds
1.89%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
11
Increased
15
Reduced
37
Closed
15
Calls
$2K
Puts
–
Net Calls
+$2K
Net Calls Change
-$522K
Top Buyers
| 1 |
1
Goldman Sachs
New York
|
$23M |
| 2 |
2
Jane Street
New York
|
$6.81M |
| 3 |
SCP
3
Syntal Capital Partners
Midland,
Texas
|
$2.68M |
| 4 |
SPIA
4
Steward Partners Investment Advisory
New York
|
$817K |
| 5 |
DS
5
DRW Securities
Chicago,
Illinois
|
$599K |
